Skip to main content
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

YS Biopharma Co., Ltd. - Ordinary Shares (NQ: YS )

1.320 UNCHANGED
Streaming Delayed Price Updated: 3:59 PM EDT, May 26, 2023 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Price and Volume

Detailed Quote
Volume 510
Open 1.320
Bid (Size) 1.350 (5)
Ask (Size) 1.420 (9)
Prev. Close 1.320
Today's Range 1.320 - 1.320
52wk Range 1.120 - 12.93
Shares Outstanding N/A
Dividend Yield N/A
Chart for (: )
Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

Top News

More News
Top 5 Health Care Stocks That Could Blast Off In May
The most oversold stocks in the health care sector presents an opportunity to buy into undervalued companies. 
Via Benzinga
12 Health Care Stocks Moving In Tuesday's Pre-Market Session
 
Via Benzinga

Performance

YTD
-86.98%
-86.98%
1 Month
-27.47%
-27.47%
3 Month
-86.98%
-86.98%
6 Month
-86.98%
-86.98%
1 Year
-86.98%
-86.98%

More News

Read More
YS, SMIH LOSS ALERT: ROSEN, A GLOBALLY RECOGNIZED LAW FIRM, Encourages YS Biopharma Co., Ltd. f/k/a Summit Healthcare Acquisition Corp. Investors to Inquire About Securities Class Action Investigation - YS, SMIH
Via NewMediaWire
NASDAQ: YS Investor Alert: Investigation over Possible Securities Laws Violations by YS Biopharma Co., Ltd.
Via SBWire
12 Health Care Stocks Moving In Friday's Intraday Session
Via Benzinga
Why YS Biopharma Stock Is Plunging Today
Via Benzinga
12 Health Care Stocks Moving In Friday's Pre-Market Session
Via Benzinga
Top 5 Health Care Stocks That Are Preparing To Pump In Q2
Via Benzinga
INVESTIGATION REMINDER: The Schall Law Firm Announces it is Investigating Claims Against YS Biopharma Co., Ltd. and Encourages Investors with Losses to Contact the Firm
From The Schall Law Firm
Via Business Wire
ROSEN, SKILLED INVESTOR COUNSEL, Encourages YS Biopharma Co., Ltd. f/k/a Summit Healthcare Acquisition Corp. Investors to Inquire About Securities Class Action Investigation - YS, SMIH
Via NewMediaWire
INVESTIGATION ALERT: The Schall Law Firm Announces it is Investigating Claims Against YS Biopharma Co., Ltd. and Encourages Investors with Losses to Contact the Firm
From The Schall Law Firm
Via Business Wire
EQUITY ALERT: ROSEN, LEADING TRIAL ATTORNEYS, Encourages YS Biopharma Co., Ltd. f/k/a Summit Healthcare Acquisition Corp. Investors to Inquire About Securities Class Action Investigation – YS, SMIH
From The Rosen Law Firm, P.A.
Via Business Wire
12 Health Care Stocks Moving In Tuesday's Pre-Market Session
Via Benzinga
Why Glory Star New Media Group Shares Are Trading Higher By 122%? Here Are Other Stocks Moving In Tuesday's Mid-Day Session
Via Benzinga
Why Kura Sushi Shares Are Trading Lower By Around 9%? Here Are Other Stocks Moving In Wednesday's Mid-Day Session
Via Benzinga
Stocks That Hit 52-Week Lows On Friday
Via Benzinga
Week In Review: Apollomics Merges With SPAC To Support Candidates Targeting Difficult-To-Treat Cancers
Via Talk Markets
Stocks That Hit 52-Week Lows On Monday
Via Benzinga
Stocks That Hit 52-Week Lows On Friday
Via Benzinga
Why Bed Bath & Beyond Shares Are Trading Lower By 15%? Here Are Other Stocks Moving In Thursday's Mid-Day Session
Via Benzinga
Stocks That Hit 52-Week Lows On Wednesday
Via Benzinga
Stocks That Hit 52-Week Lows On Tuesday
Via Benzinga
Nasdaq Edges Lower; Unity Biotechnology Shares Plummet
Via Benzinga
Why Jounce Therapeutics Shares Are Trading Higher By 23%? Here Are Other Stocks Moving In Monday's Mid-Day Session
Via Benzinga
Stocks That Hit 52-Week Lows On Monday
Via Benzinga
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.